As shown in Figure 2, cancer cells showed variable levels of Spry1. While almost undetectable in CAOV-3 cells, Spry1 was expressed by other cells, more remarkably by 1A9, suggesting that Spry1 is differentially expressed in human epithelial ovarian cancer cells in vitro. Here, SPRY1 is linked to ovarian carcinoma.